Morten Ruhwald


Morten Ruhwald, MD, PhD leads the TB programme at FIND in Geneva, Switzerland. Prior to joining FIND Morten was Chief Medical Officer at Statens Serum Institut in Copenhagen, Denmark where he oversaw the clinical development of TB and Chlamydia vaccines and specific skin tests for TB infection. At FIND Morten is responsible for a large portfolio of development projects and clinical trials spanning biomarkers, immunoassay e.g. next generation LAM assays; molecular assays for TB detection and drug resistance detection; digital diagnostics and AI based tools. A key aim of the program is to develop and trial new non-sputum based tests and sampling strategies to prepare for the post pandemic recovery of TB programs in LMICs